Figure 1 (Bimzelx 01)
Bimzelx Injection, Solution
Product Images NDC 50474-780
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Bimzelx (NDC 50474-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ucb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Bimzelx 02)
The given text contains information regarding the PASI90 Response Rate for different treatment groups over a period of 48 weeks. The treatment groups include Bimekizumab 320mg Q4W/Placebo, Bimekizumab 320mg Q4W/Bimekizumab 320mg Q8W, and Bimekizumab 320mg Q4W/Bimekizumab 320mg Q4W. The number of participants in each group is mentioned, with the first group having 105 participants, the second group having 100 participants, and the third group having 106 participants.*
Figure A (Bimzelx 03)
Figure B (Bimzelx 04)
Figure C (Bimzelx 05)
Figure D (Bimzelx 06)
Figure E (Bimzelx 07)
Figure F (Bimzelx 08)
Figure G (Bimzelx 09)
Figure H (Bimzelx 10)
Figure I (Bimzelx 11)
Figure A (Bimzelx 12)
Figure B (Bimzelx 13)
Figure C (Bimzelx 14)
Figure D (Bimzelx 15)
Figure E (Bimzelx 16)
Figure F (Bimzelx 17)
Figure G (Bimzelx 18)
Figure H (Bimzelx 19)
Figure I (Bimzelx 20)
Figure J (Bimzelx 21)
Principal Display Panel (160 mg/mL Autoinjector Carton)
Principal Display Panel (160 mg/mL Syringe Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
